Jennifer Jarrett, Chief Operating Officer at Arcus Biosciences, Inc. (RCUS), sold 19,234 shares at $31.62 ($608K) on 2022-03-16, disclosed to the SEC on 2022-03-18.
Open-market sale of $608k RCUS by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.62 | 9,617 | $304K | 50.0% |
| 2 | $31.62 | 9,617 | $304K | 50.0% |
| Total | $31.62 avg | 19,234 | $608K | 100% |
| Filing → |
| RCUS | SELL | 2025-10-08 | $1.3M | — | Filing → |
| RCUS | SELL | 2024-03-29 | $405K | — | Filing → |
| RCUS | SELL | 2024-03-20 | $458K | — | Filing → |